Quantum BioPharma Ltd. (QNTM:NASDAQ) closed at $2.27 on October 22, 2026, down 5.42% on the day. The stock trades 84.7% below its 52-week high of $14.86 and 9.7% above its 52-week low of $2.07. Over the past year, it lost 84.3%. Quantum BioPharma Ltd. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, QNTM closed higher on 97 days (38%). Its best day was March 24, 2026 (+52.58%) and its worst was March 11, 2026 (-25.00%). The stock moved 10% or more in a single session 36 times. It opened at least 5% above the previous day's high 3 times.
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. The three licensed drug candidates are LUCID-MS, a new chemical entity targeting multiple sclerosis, LUCID-PSYCH, a psychoactive molecule targeting major depressive disorder, and FSD-PEA, an ultra-micronized palmitoyl ethylamine with a favorable safety profile targeting inflammation.
Find more stocks like QNTM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.